Castle Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Castle Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 60% to $219,788,000. The net income raised on -$57,466,000 and profit margin reached -26%. Total operating expenses were $242,783,000.

Profit Margin

Castle Biosciences, Inc. (NASDAQ:CSTL): Profit margin
2017 13.75M -12.36M -89.93%
2018 22.78M -6.36M -27.94%
2019 51.86M 5.27M 10.17%
2020 62.64M -10.28M -16.42%
2021 94.08M -31.29M -33.26%
2022 137.03M -67.13M -48.99%
2023 219.78M -57.46M -26.15%

CSTL Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
219.78M137.03M94.08M62.64M51.86M22.78M13.75M
Cost of revenue
44.98M32.00M15.82M9.68M7.31M5.29M4.92M
Gross profit
174.80M105.03M78.26M52.96M44.55M17.48M8.83M
Operating exp.
Research and development
53.61M44.90M29.64M13.25M7.38M4.85M4.47M
Selling and marketing
113.65M86.60M00000
Total operating expenses
242.78M196.17M118.34M59.50M37.22M21.32M19.73M
Operating income
-67.97M-91.14M-40.07M-6.54M4.70M-3.83M-10.89M
Other income (expenses), net
10.61M22.23M67K-3.65M642K-272.41K-1.46M
Income before tax
-57.36M-68.90M-40.01M-10.2M5.34M-6.35M-12.35M
Income tax expense
101K-1.76M-8.72M84K72K8.60K9.73K
Net income
-57.46M-67.13M-31.29M-10.28M5.27M-6.36M-12.36M
Earnings per share
Basic EPS
-2.14-2.58-1.24-0.540.35-0.6-1.26
Diluted EPS
-2.14-2.58-1.24-0.54-0.21-0.6-1.26
Data sourceData sourceData sourceData sourceData source